Walleye Capital
GH icon

Walleye Capital’s Guardant Health GH Stock Holding History

Walleye Capital’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,600
Closed -$425K – 4885
2026
Q1 		$425K Sell
4,600
-14,700
-76% -$1.48M ﹤0.01% 2788
2025
Q4 		$1.97M Sell
19,300
-17,300
-47% -$1.55M 0.01% 1887
2025
Q3 		$2.29M Buy
36,600
+24,300
+198% +$1.32M 0.01% 1464
2025
Q2 		$640K Buy
12,300
+10,600
+624% +$473K ﹤0.01% 2426
2025
Q1 		$72.4K Sell
1,700
-6,400
-79% -$276K ﹤0.01% 3736
2024
Q4 		$247K Sell
8,100
-12,100
-60% -$340K ﹤0.01% 3591
2024
Q3 		$463K Sell
20,200
-28,800
-59% -$815K ﹤0.01% 3364
2024
Q2 		$1.42M Buy
49,000
+44,100
+900% +$1.03M ﹤0.01% 2472
2024
Q1 		$101K Sell
4,900
-3,100
-39% -$66.5K ﹤0.01% 4391
2023
Q4 		$216K Sell
8,000
-3,800
-32% -$99.7K ﹤0.01% 3629
2023
Q3 		$350K Sell
11,800
-700
-6% -$24.6K ﹤0.01% 3105
2023
Q2 		$448K Buy
12,500
+4,300
+52% +$123K ﹤0.01% 2528
2023
Q1 		$192K Sell
8,200
-9,300
-53% -$266K ﹤0.01% 2503
2022
Q4 		$476K Buy
17,500
+16,100
+1,150% +$737K 0.01% 1487
2022
Q3 		$75K Buy
+1,400
New +$71.9K ﹤0.01% 2511
2020
Q1 		– Sell
-400
Closed -$31K – 1202
2019
Q4 		$31K Sell
400
-100
-20% -$7.21K ﹤0.01% 1564
2019
Q3 		$32K Sell
500
-500
-50% -$44K ﹤0.01% 1678
2019
Q2 		$86K Buy
+1,000
New +$76.4K 0.01% 1261

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Walleye Capital's GH Position: Q2 2026 in Review

Walleye Capital reduced its Guardant Health (GH) stake by 64% in Q2 2026, selling an estimated $20.4M and leaving 104,527 shares worth $15.7M. The position accounts for 0.06% of the portfolio, ranked #311.

Walleye Capital first reported a position in GH in Q4 2019 and has held it in 19 quarters since. The position peaked at $27M in Q1 2026. 600 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Walleye Capital held 104,527 shares of Guardant Health worth $15.7M as of Q2 2026.
  • Walleye Capital sold 187,399 Guardant Health shares in Q2 2026, an estimated $20.4M.
  • Guardant Health made up 0.06% of Walleye Capital's portfolio in Q2 2026, its #311 holding.
  • Walleye Capital first reported a position in Guardant Health in Q4 2019 and has held it in 19 quarters since.
  • Walleye Capital's Guardant Health position peaked at $27M in Q1 2026.
  • 600 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.